Starting tirzepatide: four first-month checkpoints

1. When the shipment arrives: match the materials

Check the prescribed product, the pharmacy label, the supplied equipment and the current written instructions. Locate storage directions and the relevant discard timing. If the item, concentration or directions differ from what you expected, contact the prescribing or dispensing team before using it.

For a compounded injectable that arrives warm or without adequate refrigeration, FDA advises not using it. Contact the compounder or telehealth service about the shipment. An intact-looking box is not enough to establish that a temperature-sensitive medicine was handled correctly.

2. Before the first injection: confirm teaching and disposal

Ask for training matched to your actual product. In our supplies-and-training guide, the read-back exercise pairs the current label and equipment with the explanation, so unresolved details become clear before use.

Also have a suitable sharps container available and a plan to keep it away from children and pets. Our GLP-1 disposal guide explains both immediate containment and the eventual local disposal route. Finding a place for a used needle should be part of preparation.

3. After doses: describe what happens without a timetable promise

The Zepbound medication guide lists nausea, diarrhea, vomiting, constipation and other possible adverse effects. Experiences vary. A week-two improvement or a specific number of pounds lost by week three cannot be promised to an individual.

Record the medicine taken and date, any symptom, when it began, how long it lasted and whether it interfered with eating, drinking or ordinary activities. Follow the monitoring plan your clinician gives you. Persistent symptoms deserve a clinical response rather than a note to wait for the next milestone.

For a routine discussion, those observations are more useful than a conclusion such as “the medicine is not working.” Ask the clinician what outcome they are assessing and which symptoms require contact sooner.

4. Before the next supply or dose decision: reconnect with the team

Dose instructions depend on the prescribed product and clinical plan. Zepbound’s prescribing information specifies a starting schedule and subsequent escalation requirements, but an educational page cannot authorize a change to your own prescription. Confirm the next step with the prescriber and obtain matching written directions.

For readers comparing CoreAge Rx, the supplies page describes what accompanies its orders and the doctor-messaging page gives typical response times of 1–3 business days. Ask early about unresolved instructions and the next check-in. Our CoreAge Rx provider review can help assess that service arrangement.

CoreAge Rx’s product overview lists compounded semaglutide and tirzepatide. These are not FDA-approved Zepbound; FDA explains the limits and appropriate role of compounding. Do not transfer a brand’s trial result or device directions to a compounded preparation automatically.

Symptoms that should not wait for a routine check-in

Zepbound’s medication guide directs patients to stop it and seek immediate medical help for a serious allergic reaction, such as face or throat swelling or trouble breathing. Call 911 for breathing difficulty or a severe reaction. It also directs patients to stop Zepbound and call the clinician immediately for severe, persistent abdominal pain, which may extend to the back.

Seek prompt clinical advice for vomiting, diarrhea or other stomach symptoms that persist, especially when you cannot keep fluids down. Get an individual plan for low blood sugar if you use insulin or another medicine that can cause it. These are selected warning signs, not a complete safety list; read the medication guide for the actual prescription.